Given that our classification relied on a visual scale of amygdalar atrophy without neuropathologic confirmation, it is plausible that cognitive trajectories in the AD/LATE group were primarily driven by AD pathology rather than TDP-43. The gene discussed is TARDBP; the disease is Alzheimer disease.